Other thoughts
Hi Kirby,
I just received an email update from AAMDS. Their November bulletin has video presentations embedded within that has presentations from the June conference. I saw a bunch of world expert names with good things to say. Worth loggin on.
I hope your doc is right that you are heading back down but I would think about a second opinion.
Steve
__________________
Steve Kessler,Age 71, Dx 3/2001, Currently AML converted from MDS, 5q-, 11q23, Negative response to Aranesp, Revlimid. Partial response to Vidaza in the past. On a study using ON1910.NA, counts too low to go to Stanford on schedule.
|